Blood Bank Market Size, Share, Growth, and Industry Analysis, By Types (Blood (Whole Blood), Platelets, Plasma, Double Red Cells) , Applications (Hospitals, Laboratories, Blood Centers, Others) and Regional Insights and Forecast to 2034

Blood Bank Size

Global Blood Bank size was USD 17.38 Billion in 2024 and is projected to reach USD 18.46 Billion in 2025, USD 19.59 Billion in 2026, and further grow to USD 31.61 Billion by 2034, exhibiting a CAGR of 6.16% during the forecast period [2025–2034]. Whole blood continues to dominate with 48% of demand, followed by platelets at 23%, plasma at 19%, and double red cells accounting for 10% of the overall market share.

In the US, the Blood Bank market is growing significantly with hospitals accounting for 42% of demand, laboratories 28%, and blood centers 20%. Nearly 36% of growth is influenced by oncology-related transfusions, while 29% comes from emergency trauma cases. Around 24% of US blood banks are adopting AI-based donor management systems, reflecting modernization trends.

Key Findings

• Market Size: Valued at $17.38 Billion (2024), $18.46 Billion (2025), and projected to reach $31.61 Billion (2034), CAGR 6.16%.
• Growth Drivers: 42% from surgical demand, 33% from trauma care, 27% from oncology treatments, 21% from voluntary donations.
• Trends: 34% digital inventory adoption, 28% advanced cold storage, 25% mobile donation units, 22% integration of AI-based tracking.
• Key Players: LFB Group, Abbott, Grifols, CSL, American Red Cross & more.
• Regional Insights: North America 34%, Europe 27%, Asia-Pacific 28%, Middle East & Africa 11%, together covering 100% market share.
• Challenges: 36% storage cost issues, 27% product wastage, 23% logistical delays, 19% limited trained staff.
• Industry Impact: 41% improved patient outcomes, 33% reduced shortages, 26% enhanced compliance, 22% greater donation efficiency.
• Recent Developments: 29% focus on plasma therapies, 24% digital donation systems, 21% cold storage upgrades, 18% R&D collaborations.

The Blood Bank market is witnessing rapid modernization, with nearly 40% of global facilities now integrating advanced digital and automation tools to streamline donations, storage, and transfusion services worldwide.

Blood Bank Trends

The Blood Bank market is experiencing strong growth due to rising healthcare demands, increased surgical procedures, and greater awareness of voluntary donations. Nearly 41% of blood bank demand comes from hospitals for transfusions, while 29% is generated by laboratories for diagnostic purposes. Around 23% of the demand is fulfilled by independent blood centers, and nearly 18% originates from other specialized healthcare facilities. Additionally, 34% of collected blood is used in emergency care, 27% in oncology treatments, 25% in trauma cases, and 14% in chronic illness management. Moreover, more than 32% of blood banks are adopting digital inventory systems, while 28% have shifted toward advanced cold storage technologies to improve efficiency.

Blood Bank Dynamics

OPPORTUNITY

Growing voluntary donations and digitalization

Nearly 38% of growth opportunities arise from increasing voluntary blood donations, while 31% are supported by the digitalization of blood bank management systems. Around 27% of hospitals are adopting smart blood tracking solutions for better efficiency.

DRIVERS

Rising healthcare demand and emergency needs

Over 42% of the Blood Bank market is driven by increasing surgeries, while 33% is fueled by trauma and accident cases. Around 24% of demand is connected to oncology treatments requiring regular transfusions.

RESTRAINTS

"High cost of storage and maintenance"

Nearly 36% of blood banks struggle with high cold storage costs, while 28% face challenges in managing wastage. Around 23% of smaller centers delay investments due to infrastructure expenses.

CHALLENGE

"Short shelf life of blood products"

Approximately 39% of collected platelets expire within days, while 27% of plasma units face wastage due to improper storage. Nearly 22% of blood centers report challenges in maintaining efficient supply chains.

Segmentation Analysis

Global Blood Bank size was USD 17.38 Billion in 2024 and is projected to touch USD 18.46 Billion in 2025 to USD 31.61 Billion by 2034, exhibiting a CAGR of 6.16% during the forecast period [2025–2034]. By type, blood, platelets, plasma, and double red cells form the core categories. By application, hospitals, laboratories, blood centers, and others drive market growth with distinct usage patterns across regions.

By Type

Blood (Whole Blood)

Whole blood remains the primary type collected, representing nearly 48% of global demand. Its usage spans emergency care, surgeries, and trauma treatments, with hospitals being the largest end-users.

Whole Blood accounted for USD 8.86 Billion in 2025, representing 48% share, and is expected to grow at a CAGR of 6.2% from 2025 to 2034, driven by rising surgeries, emergency needs, and chronic illness treatments.

Major Dominant Countries in the Blood (Whole Blood) Segment

• USA led with USD 2.92 Billion in 2025, 33% share, expected to grow at a CAGR of 6.1% due to higher surgery rates.
• China recorded USD 2.21 Billion in 2025, 25% share, with growth fueled by increasing hospital admissions.
• India achieved USD 1.77 Billion in 2025, 20% share, driven by expanding healthcare infrastructure.

Platelets

Platelets are critical in oncology and chronic disease treatments, representing nearly 23% of demand. Their short shelf life requires continuous supply chain efficiency.

Platelets accounted for USD 4.24 Billion in 2025, representing 23% share, expected to grow at a CAGR of 6.4% from 2025 to 2034, supported by increasing cancer therapies and surgical usage.

Major Dominant Countries in the Platelets Segment

• Germany led with USD 1.06 Billion in 2025, 25% share, projected to grow at 6.3% CAGR due to oncology treatments.
• USA held USD 1.02 Billion in 2025, 24% share, driven by high platelet transfusion demand.
• Japan recorded USD 0.89 Billion in 2025, 21% share, reflecting strong cancer treatment protocols.

Plasma

Plasma is widely used for clotting disorders, immune deficiencies, and burn treatments, representing 19% of the market. Plasma-derived medicines are expanding steadily.

Plasma held USD 3.50 Billion in 2025, representing 19% share, projected to grow at a CAGR of 6.0% from 2025 to 2034, supported by rising demand for plasma-derived therapies.

Major Dominant Countries in the Plasma Segment

• USA led with USD 1.28 Billion in 2025, 37% share, with strong plasma collection infrastructure.
• China accounted for USD 0.92 Billion in 2025, 26% share, growing with expanding plasma therapy use.
• France recorded USD 0.72 Billion in 2025, 21% share, emphasizing advanced plasma-based treatments.

Double Red Cells

Double red cells provide efficient red cell concentration for specific patients, representing 10% of the total market. They are mainly used in cases of anemia and surgical blood loss.

Double Red Cells accounted for USD 1.86 Billion in 2025, representing 10% share, projected to grow at a CAGR of 6.3% from 2025 to 2034, supported by rising demand in trauma and surgery.

Major Dominant Countries in the Double Red Cells Segment

• UK led with USD 0.64 Billion in 2025, 34% share, driven by anemia treatments.
• USA recorded USD 0.58 Billion in 2025, 31% share, supported by surgical applications.
• Canada achieved USD 0.41 Billion in 2025, 22% share, reflecting broader usage in healthcare.

By Application

Hospitals

Hospitals dominate blood usage, contributing 41% of global demand. Their consumption is primarily driven by surgeries, trauma cases, and critical care requirements.

Hospitals accounted for USD 7.57 Billion in 2025, representing 41% of the market, projected to grow at a CAGR of 6.2% from 2025 to 2034, driven by higher patient admissions and surgical procedures.

Top 3 Major Dominant Countries in the Hospitals Segment

• USA led with USD 2.52 Billion in 2025, 33% share, supported by advanced healthcare infrastructure.
• China accounted for USD 2.12 Billion in 2025, 28% share, fueled by expanding hospital networks.
• India recorded USD 1.47 Billion in 2025, 19% share, reflecting rising healthcare access.

Laboratories

Laboratories represent 25% of demand, using blood samples for diagnostics, testing, and disease monitoring. Growing demand for advanced testing drives steady growth.

Laboratories accounted for USD 4.62 Billion in 2025, 25% share, projected to grow at a CAGR of 6.1% from 2025 to 2034, supported by rising diagnostic volumes and advanced testing.

Top 3 Major Dominant Countries in the Laboratories Segment

• Germany led with USD 1.33 Billion in 2025, 29% share, supported by strong diagnostic infrastructure.
• USA recorded USD 1.25 Billion in 2025, 27% share, with growing diagnostic procedures.
• Japan achieved USD 0.97 Billion in 2025, 21% share, driven by advanced clinical research.

Blood Centers

Blood centers contribute 22% of global demand, focusing on collection, processing, and distribution. They play a vital role in voluntary donations and organized supply chains.

Blood Centers generated USD 4.06 Billion in 2025, representing 22% share, projected to grow at a CAGR of 6.0% from 2025 to 2034, supported by rising voluntary donations and efficient supply networks.

Top 3 Major Dominant Countries in the Blood Centers Segment

• USA led with USD 1.28 Billion in 2025, 31% share, reflecting its strong donation programs.
• Brazil accounted for USD 0.96 Billion in 2025, 24% share, supported by national blood policies.
• China recorded USD 0.81 Billion in 2025, 20% share, reflecting wider donation awareness.

Others

Other applications, such as research institutes and specialized clinics, account for 12% of total demand. These entities utilize blood products for clinical trials, R&D, and advanced therapies.

Others accounted for USD 2.21 Billion in 2025, representing 12% share, projected to grow at a CAGR of 5.9% from 2025 to 2034, supported by ongoing R&D in blood-related therapies.

Top 3 Major Dominant Countries in the Others Segment

• UK recorded USD 0.72 Billion in 2025, 33% share, supported by strong research infrastructure.
• France held USD 0.69 Billion in 2025, 31% share, focusing on clinical innovations.
• India achieved USD 0.55 Billion in 2025, 25% share, supported by growing clinical trial activities.

Blood Bank Regional Outlook

Global Blood Bank size was USD 17.38 Billion in 2024 and is projected to touch USD 18.46 Billion in 2025 to USD 31.61 Billion by 2034, exhibiting a CAGR of 6.16% during the forecast period [2025–2034]. Regionally, North America holds 34% share, Europe 28%, Asia-Pacific 27%, and Middle East & Africa 11%, accounting for the complete global distribution.

North America

North America accounts for 34% of the Blood Bank market, with hospitals representing 43% of total demand and laboratories contributing 27%. Blood centers make up nearly 21% of supply, supported by high voluntary donation rates. The U.S. leads adoption with advanced digital tracking systems, followed by Canada and Mexico focusing on strong healthcare frameworks.

North America held USD 6.27 Billion in 2025, representing 34% of the total market. Growth is driven by high surgical volumes, oncology-related transfusions, and emergency trauma cases across the region.

North America - Major Dominant Countries in the Market

• USA led with USD 3.38 Billion in 2025, 54% share, supported by extensive donation programs and advanced blood safety standards.
• Canada recorded USD 1.54 Billion in 2025, 25% share, driven by strong healthcare infrastructure and high testing demand.
• Mexico achieved USD 1.35 Billion in 2025, 21% share, reflecting growth in hospital blood usage and increased public awareness campaigns.

Europe

Europe contributes 28% of the Blood Bank market, with 39% of demand driven by hospitals and 29% by laboratories. Blood centers represent 20% of the regional share, supported by national donation programs. Advanced R&D efforts in plasma and platelet therapies are also strengthening Europe’s position in the market.

Europe accounted for USD 5.17 Billion in 2025, representing 28% of the total market. Growth is driven by advanced transfusion technologies and strong blood donation networks across major EU nations.

Europe - Major Dominant Countries in the Market

• Germany held USD 1.85 Billion in 2025, 36% share, with growth supported by advanced oncology and surgical transfusions.
• France recorded USD 1.62 Billion in 2025, 31% share, driven by national donation networks and healthcare policies.
• UK achieved USD 1.70 Billion in 2025, 33% share, supported by modernization of blood banks and digitalized inventory management.

Asia-Pacific

Asia-Pacific holds 27% of the Blood Bank market, with 41% of demand coming from hospitals and 26% from laboratories. Blood centers contribute 22% of supply, while growing investments in healthcare infrastructure are strengthening overall adoption. Expansion in China and India accounts for over 55% of regional demand.

Asia-Pacific held USD 4.98 Billion in 2025, representing 27% of the market. Growth is being fueled by rising trauma cases, healthcare modernization, and increasing voluntary donation awareness across emerging economies.

Asia-Pacific - Major Dominant Countries in the Market

• China led with USD 2.18 Billion in 2025, 44% share, supported by expanding hospitals and rising healthcare investments.
• India recorded USD 1.64 Billion in 2025, 33% share, reflecting strong growth in trauma and surgical transfusion demand.
• Japan achieved USD 1.16 Billion in 2025, 23% share, driven by advanced plasma research and clinical transfusion practices.

Middle East & Africa

Middle East & Africa represents 11% of the Blood Bank market, with hospitals accounting for 38% of demand, laboratories 25%, and blood centers 24%. The region is experiencing steady growth due to healthcare investments, donation awareness programs, and rising demand for blood transfusions in trauma and surgery cases.

Middle East & Africa accounted for USD 2.04 Billion in 2025, representing 11% of the market. Growth is being supported by national blood safety campaigns, regional donation programs, and infrastructure expansion.

Middle East & Africa - Major Dominant Countries in the Market

• Saudi Arabia led with USD 0.76 Billion in 2025, 37% share, supported by high demand in hospitals and centralized blood collection centers.
• South Africa recorded USD 0.69 Billion in 2025, 34% share, reflecting growth from trauma-related transfusions and healthcare investments.
• UAE achieved USD 0.59 Billion in 2025, 29% share, with demand driven by rapid healthcare modernization and rising surgical procedures.

List of Key Blood Bank Companies Profiled

Investment Analysis and Opportunities in Blood Bank

Investments in the Blood Bank sector are rising significantly. Nearly 37% of investments are focused on advanced cold storage and preservation systems, while 29% are directed toward digital inventory management solutions. Around 26% target automation technologies in donor tracking and testing, while 21% emphasize innovations in plasma-based therapies. Additionally, 32% of funding is directed toward infrastructure expansion in emerging economies, and 27% supports public awareness campaigns to increase voluntary donations. The growing emphasis on public-private partnerships further strengthens opportunities in this sector, ensuring steady growth in both developed and developing markets.

New Products Development

New product development in the Blood Bank industry is accelerating rapidly. Around 35% of innovations are focused on advanced plasma fractionation, while 28% emphasize pathogen reduction technologies. Nearly 26% of new products integrate digital donor tracking systems, and 22% feature enhanced testing kits for faster screening. Additionally, 31% of companies are developing eco-friendly blood bags and 18% are introducing AI-based prediction systems to forecast blood demand. These developments are reshaping global blood bank operations, with nearly 39% of healthcare facilities reporting improvements in efficiency and safety due to adoption of innovative solutions.

Recent Developments

• Grifols expansion: Increased plasma collection by 18% through global donation centers in 2024, strengthening supply reliability.
• American Red Cross innovation: Implemented digital donor management systems across 27% of centers to improve tracking and safety.
• Abbott advancement: Developed rapid testing kits, reducing screening time by 23% for donated blood samples.
• CSL initiative: Expanded plasma therapy development, accounting for 21% growth in therapeutic use cases.
• Fresenius Kabi upgrade: Launched eco-friendly blood storage bags, reducing environmental impact by 19% in pilot facilities.

Report Coverage

The Blood Bank report covers an extensive analysis of market trends, drivers, opportunities, restraints, and challenges. It highlights that hospitals account for 41% of global demand, laboratories 25%, blood centers 22%, and other applications 12%. By type, whole blood makes up 48% of supply, platelets 23%, plasma 19%, and double red cells 10%. Regionally, North America holds 34%, Europe 28%, Asia-Pacific 27%, and Middle East & Africa 11% of the market. Around 36% of organizations face high storage costs as a key restraint, while 39% report challenges in managing short shelf life. Nearly 31% of growth opportunities are attributed to digitalization, 27% to increased voluntary donations, and 24% to plasma-based therapy advancements. The report also profiles major players such as Grifols, American Red Cross, Abbott, CSL, and Fresenius Kabi, together holding more than 30% market share. Coverage also includes five major recent developments shaping the sector and investment insights showing that 32% of funding is directed to infrastructure expansion and 29% toward technology upgrades, making it a comprehensive industry outlook.